198 related articles for article (PubMed ID: 2553289)
1. Inhibition by lipoxygenase inhibitors of 7-bromomethylbenz[a]anthracene-caused epidermal ornithine decarboxylase induction and skin tumor promotion in mice.
Nakadate T; Yamamoto S; Aizu E; Kato R
Carcinogenesis; 1989 Nov; 10(11):2053-7. PubMed ID: 2553289
[TBL] [Abstract][Full Text] [Related]
2. Anti-tumor promoting action of phthalic acid mono-n-butyl ester cupric salt, a biomimetic superoxide dismutase.
Yamamoto S; Nakadate T; Aizu E; Kato R
Carcinogenesis; 1990 May; 11(5):749-54. PubMed ID: 2110512
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of 7-bromomethylbenz[a]anthracene-promoted mouse skin tumor formation by retinoic acid and dexamethasone.
Verma AK; Garcia CT; Ashendel CL; Boutwell RK
Cancer Res; 1983 Jul; 43(7):3045-9. PubMed ID: 6406052
[TBL] [Abstract][Full Text] [Related]
4. The potent anti-tumor-promoting agent isoliquiritigenin.
Yamamoto S; Aizu E; Jiang H; Nakadate T; Kiyoto I; Wang JC; Kato R
Carcinogenesis; 1991 Feb; 12(2):317-23. PubMed ID: 1899810
[TBL] [Abstract][Full Text] [Related]
5. Involvement of prostaglandin E2 in ornithine decarboxylase induction by a tumor-promoting agent, 7-bromomethylbenz[a]anthracene, in mouse epidermis.
Yamamoto S; Jiang H; Otsuka C; Kato R
Carcinogenesis; 1992 May; 13(5):905-6. PubMed ID: 1587007
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-mediated epidermal ornithine decarboxylase induction and skin tumor promotion by new lipoxygenase inhibitors lacking protein kinase C inhibitory effects.
Aizu E; Nakadate T; Yamamoto S; Kato R
Carcinogenesis; 1986 Nov; 7(11):1809-12. PubMed ID: 3094975
[TBL] [Abstract][Full Text] [Related]
7. Differential inhibition by staurosporine, a potent protein kinase C inhibitor, of 12-O-tetradecanoylphorbol-13-acetate-caused skin tumor promotion, epidermal ornithine decarboxylase induction, hyperplasia and inflammation.
Yamamoto S; Kiyoto I; Aizu E; Nakadate T; Hosoda Y; Kato R
Carcinogenesis; 1989 Jul; 10(7):1315-22. PubMed ID: 2544313
[TBL] [Abstract][Full Text] [Related]
8. Effects of flavonoids and antioxidants on 12-O-tetradecanoyl-phorbol-13-acetate-caused epidermal ornithine decarboxylase induction and tumor promotion in relation to lipoxygenase inhibition by these compounds.
Nakadate T; Yamamoto S; Aizu E; Kato R
Gan; 1984 Mar; 75(3):214-22. PubMed ID: 6427052
[TBL] [Abstract][Full Text] [Related]
9. Inhibition by putrescine of the induction of epidermal ornithine decarboxylase activity and tumor promotion caused by 12-O-tetradecanoylphorbol-13-acetate.
Weekes RG; Verma AK; Boutwell RK
Cancer Res; 1980 Nov; 40(11):4013-8. PubMed ID: 7471050
[TBL] [Abstract][Full Text] [Related]
10. The induction of ornithine decarboxylase caused by 12-O-tetradecanoylphorbol-13-acetate in isolated epidermal cells is inhibited by lipoxygenase inhibitors but not by cyclooxygenase inhibitors.
Yamamoto S; Sasakawa N; Kiyoto I; Nakadate T; Kato R
Eur J Pharmacol; 1987 Nov; 144(1):101-3. PubMed ID: 3125055
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion and ornithine decarboxylase activity by quercetin: possible involvement of lipoxygenase inhibition.
Kato R; Nakadate T; Yamamoto S; Sugimura T
Carcinogenesis; 1983 Oct; 4(10):1301-5. PubMed ID: 6413085
[TBL] [Abstract][Full Text] [Related]
12. Effects of combined treatments with selenium, glutathione, and vitamin E on glutathione peroxidase activity, ornithine decarboxylase induction, and complete and multistage carcinogenesis in mouse skin.
Perchellet JP; Abney NL; Thomas RM; Guislain YL; Perchellet EM
Cancer Res; 1987 Jan; 47(2):477-85. PubMed ID: 3098411
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of teleocidin-caused epidermal ornithine decarboxylase induction by phospholipase A2-, cyclooxygenase- and lipoxygenase-inhibitors.
Nakadate T; Aizu E; Yamamoto S; Fujiki H; Sugimura T; Kato R
Jpn J Pharmacol; 1985 Mar; 37(3):253-8. PubMed ID: 3923244
[TBL] [Abstract][Full Text] [Related]
14. Induction of mouse epidermal ornithine decarboxylase activity and skin tumors by 7,12-dimethylben.
Verma AK; Conrad EA; Boutwell RK
Carcinogenesis; 1980 Jul; 1(7):607-11. PubMed ID: 11219836
[TBL] [Abstract][Full Text] [Related]
15. Tumor promoter-induced refractory state against ornithine decarboxylase induction by 12-O-tetradecanoylphorbol-13-acetate in mouse epidermis.
Takigawa M; Simsiman RC; Boutwell RK
Cancer Res; 1986 Jan; 46(1):106-12. PubMed ID: 3940182
[TBL] [Abstract][Full Text] [Related]
16. Involvement of protein kinase C activation in ornithine decarboxylase gene expression in primary culture of newborn mouse epidermal cells and in skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate.
Verma AK; Pong RC; Erickson D
Cancer Res; 1986 Dec; 46(12 Pt 1):6149-55. PubMed ID: 3779635
[TBL] [Abstract][Full Text] [Related]
17. Staurosporine, a potent protein kinase C inhibitor, augments phorbol ester-caused ornithine decarboxylase induction in mouse epidermis.
Jiang H; Yamamoto S; Kato R
Carcinogenesis; 1992 Mar; 13(3):355-9. PubMed ID: 1547524
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of phorbol ester-caused induction of ornithine decarboxylase and tumor promotion in mouse skin by staurosporine, a potent inhibitor of protein kinase C.
Yamada S; Hirota K; Chida K; Kuroki T
Biochem Biophys Res Commun; 1988 Nov; 157(1):9-15. PubMed ID: 3196353
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the effect of sn-1,2-didecanoylglycerol and 12-O-tetradecanoylphorbol-13-acetate on cutaneous morphology, inflammation and tumor promotion in CD-1 mice.
Smart RC; Huang MT; Monteiro-Riviere NA; Wong CQ; Mills KJ; Conney AH
Carcinogenesis; 1988 Dec; 9(12):2221-6. PubMed ID: 3191568
[TBL] [Abstract][Full Text] [Related]
20. Modulation of chrysarobin skin tumor promotion.
DiGiovanni J; Kruszewski FH; Chenicek KJ
Carcinogenesis; 1988 Aug; 9(8):1445-50. PubMed ID: 3135955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
